last update more than 15 m growth in GP in PP , more than 30 m GP in Branded products and 1.2 m growth in international , reduction in OPEX in both dermatology and PP and increase in OPEX in branded products for a bigger market share , directing cost to priority women health products to have a bigger market share across 50 us states to have a share in 5 billion contraceptive sale across usa and give women more coc option and become a destination in women health and the go to with all prescribers considering mayne pharma products
last update more than 15 m growth in GP in PP , more than 30 m...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.03 |
Change
-0.170(3.27%) |
Mkt cap ! $408.6M | |||
| Open | High | Low | Value | Volume |
| $5.20 | $5.21 | $5.03 | $2.804M | 555.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14654 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.14 | 3111 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |